Category Archives: Endocrinology

Three-year study examines trans women’s breast development from feminizing HRT

For trans women and transfeminine people who are considering or at the very beginning of feminizing hormone therapy, one of the most common points of concern – and uncertainty – is breast development. How soon will it start, how fast … Continue reading

Posted in Breast, Endocrinology, Outcomes of transition, Progestogens, Transfeminine | Tagged , , | Leave a comment

Trans men and transmasculine people on testosterone can grow prostate tissue

The general public’s knowledge of the nature of the physical changes induced by medical transition can be surprisingly spotty: trans women’s breasts are often wrongly assumed to be implants; our long-healed neovaginas are cruelly mischaracterized as “open wounds”; HRT is … Continue reading

Posted in Biology of transition, Endocrinology, Transmasculine | Tagged , , | 2 Comments

Open questions: Trans men and transmasculine people can experience abdominal and pelvic pain after starting testosterone

Collaboration between the transgender community and health researchers plays an essential role in ensuring that our population’s knowledge and interests are acknowledged and represented in medicine. When researchers neglect to reach out and utilize the community’s collected experiences and shared … Continue reading

Posted in Endocrinology, Transgender medicine, Transmasculine | Tagged , , , | 1 Comment

Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading

Posted in Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | 1 Comment

Once-yearly implanted puberty blockers may last for two years or more

Disclaimer: I am not a medical professional and this is not medical advice. GnRH agonists are a class of medications that reversibly block the progression of natal puberty both in cis youth with precocious (early) puberty and in trans adolescents, … Continue reading

Posted in Endocrinology, Trans youth, Transgender medicine | Tagged , , , , | Leave a comment